ResMed Inc.
$228.42
$0.17 (+0.07%)
$225.08Day Range$229.57
Key Statistics
Market Cap
$32.93B
Shares Outstanding
144.3M
Primary Exchange
XNYS
Currency
USD
Type
CS
IPO Date
Jun 2, 1995
Round Lot
100
Locale
US
Trading Data
Day Open
$228.25
Day High
$229.57
Day Low
$225.08
Volume
1.09M
VWAP
$227.77
Prev Close
$228.25
Transactions
--
Acc. Volume
--
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 384111,370 employees9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123(858) 746-2400IPO Jun 2, 1995US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000943819
- Composite FIGI
- BBG000L4M7F1
- Share Class FIGI
- BBG001SBGRC2
- Ticker Root
- RMD
- SIC Code
- 3841
About ResMed Inc. (RMD) Stock
ResMed Inc. (RMD) closed the 2026-09-17 session at $228.42, up 0.07% versus the previous close (+0.17). The stock opened at $228.25 and traded between $225.08 and $229.57 during that session. Session trading volume was 1.1M shares. The volume-weighted average price (VWAP) is $227.77.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.
ResMed Inc. has a market capitalization of $32.93 billion. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. RMD is listed on the XNYS exchange. The company employs approximately 11,370 people. ResMed Inc. is headquartered in SAN DIEGO, CA. The recorded listing date is 1995-06-02.
On this page you can find market RMD stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.